Delivery Order SPE2DB22D1202-SPE2DB24FVFW9

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,451.40 firm-fixed-price delivery order has a completion date of June 25, 2024 and was awarded on June 24, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $1,741.68 and a completion date of June 5, 2024. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the provision of Trulicity 0.75 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,451.40 and an ultimate completion date of May 14, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $4,441.75 and a completion date of April 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 0.75 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,816.16 and an ultimate completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $32,349.59 and an ultimate completion date of April 10, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed price basis. The contract is a delivery order and does not have a set-aside designation. In addition to this award,...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,483.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. This award is part of a larger indefinite delivery contract (IDC) with a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $1,456.86, has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp, which has a for-profit business structure, serves as the prime contractor under this award. This contract is not designated as a set-aside....
This federal contract award is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $4,103.64 firm fixed price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of June 27, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) is for the delivery of Trulicity 0.75 mg/0.5 ml pens in support of military treatment programs and facilities. The $1,015.98 firm fixed price delivery order has a completion date of January 18, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this contract, which is not designated as a set-aside. The company also holds a...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVFW9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,621.85 and an ultimate completion date of July 5, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation.

Generated 10/2/24, 9:44 AM